Archive · 25 Jul 2025
Syngene International Shares Rise Amidst Weak Market
Imagine a company called Syngene, which does well even when the stock market isn't doing great.
They just announced how much money they made in the first three months of the year, and it's good news!
They made more money than last year.
The people in charge think things will keep going well.
They are building new places to make things.
Experts are looking at the numbers and have good things to say.
However, they also say that some new people they hired might not really help until later.
So far so good for this company!
Syngene International's share price rose over 2% despite weak Indian stock markets.
Q1 FY26 results showed a 59% year-on-year increase in adjusted net profit to ₹87 crore.
Revenue from operations increased by 11% year-on-year to ₹875 crore.
Management expects the momentum to continue and plans to meet annual guidance.
Jefferies expects benefits from senior hires at overseas pharma hubs to be realized from FY27/28.
- Who
- Syngene International, Peter Bains (MD and CEO), and Jefferies India Pvt Ltd.
- What
- Syngene International's share price increased despite market conditions, with positive Q1 results.
- When
- Q1 results were reported on Wednesday.
- Where
- In India and the US
- Why
- The share price increase was driven by positive Q1 results and expectations of continued momentum.
Analysts
Management
Future Outlook
Analysts
Jefferies expects benefits from senior hires to be realized from FY27/28
Management
Management has reiterated FY26 guidance, indicating near-term headwinds.
- Share Price Movement
- Up 2%+
- Q1 FY26 Adjusted Net Profit
- ₹87 crore
- Year-on-Year Profit Increase
- 59%
- Revenue from Operations
- ₹875 crore
- Year-on-Year Revenue Increase
- 11%
- EBITDA Margin
- 25%